Skip to main content
logo
Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.050
-0.080 (-3.76%)
At close: Jul 24, 2026, 4:00 PM EDT
2.000
-0.050 (-2.44%)
After-hours: Jul 24, 2026, 6:13 PM EDT

Entera Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
00.040.18-0.130.57
Revenue Growth
--76.80%---76.53%56.44%
Gross Profit
000.01-0.030.2
Operating Income
-12.51-11.53-9.59-8.89-13.02-12.22
Net Income
-12.38-11.44-9.54-8.89-13.07-12.19
Earnings Per Share
0.150.250.250.310.450.47
EPS Growth
7.14%0%-19.36%-31.11%-4.25%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.147.118.6611.0212.3124.89
Total Debt
0.450.490.270.390.090.3
Net Cash (Debt)
3.696.628.3910.6312.2224.59
Net Cash Growth
-70.14%-21.10%-21.08%-13.00%-50.31%201.31%
Net Cash Per Share
0.080.140.220.370.420.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.06-7.37-6.82-7.31-12.5-9.06
Capital Expenditures
-0.1-0.11-0-0.02-0.05-0.02
Free Cash Flow
-9.16-7.48-6.82-7.33-12.55-9.08
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-0.00%4.97%-24.63%34.68%
Operating Margin
--27450.00%-5295.58%--9714.18%-2139.58%
Pretax Margin
--27235.71%-5263.54%--9652.24%-2144.66%
Profit Margin
--27235.70%-5271.27%--9754.48%-2134.33%
FCF Margin
--17802.40%-3768.51%--9362.69%-1590.19%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-7.768.481.941.626.00
PS Ratio
-2133.01454.89-156.95142.26